Journal
CANCER INVESTIGATION
Volume 37, Issue 10, Pages 524-530Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/07357907.2019.1675076
Keywords
Localized prostate cancer; pelvic lymph node dissection; radical prostatectomy; therapeutic significance
Categories
Ask authors/readers for more resources
The oncological benefit of pelvic lymph node dissection (PLND) is still debatable because data on clinical outcomes of radical prostatectomy (RP) without PLND are lacking. In this study, we reported oncological outcome in consecutive 146 patients who underwent RP without PLND. Although 27% of our patients developed biochemical recurrence, the estimated 5-year overall survival rates were 100%, 96.3%, and 95.7% in the low-, intermediate-, and high-risk groups, respectively. These data in our patients were not inferior to those in previous reports that investigated the survivals in patients who received PLND during RP. The therapeutic significance of PLND should be re-evaluated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available